Advertisement
Screener

Enumeral Biomedical Holdings, Inc. Comprehensive Income

Enumeral Biomedical Holdings, Inc. Comprehensive Income

Enumeral Biomedical Holdings, Inc. reported Comprehensive Income of -$11.86 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-28.

Discontinued › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2017-03-28

  • Enumeral Biomedical Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-12-31 was -$7.69M, a 1981.13% decline year-over-year.
  • Enumeral Biomedical Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-09-30 was -$1.26M, a 303.93% decline year-over-year.
  • Enumeral Biomedical Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-06-30 was -$1.35M.
  • Enumeral Biomedical Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-03-31 was -$1.56M.
  • Enumeral Biomedical Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$11.86M, a 459.30% decline from fiscal 2015.
  • Enumeral Biomedical Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was $3.30M.
  • Enumeral Biomedical Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was -$8.19M.
  • Enumeral Biomedical Holdings, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2013 was -$3.86M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2016-12-31-$7.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28
-$8.95M
derived: sum of 2 quarters · filed 2017-03-28
-$10.30M
derived: sum of 3 quarters · filed 2017-03-28
-$11.86M
10-K · filed 2017-03-28
2016-09-30-$1.26M
10-Q · filed 2016-11-10
-$2.61M
derived: sum of 2 quarters · filed 2016-11-10
-$4.16M
10-Q · filed 2016-11-10
-$3.75M
derived: sum of 4 quarters · filed 2017-03-28
2016-06-30-$1.35M
10-Q · filed 2016-08-12
-$2.90M
10-Q · filed 2016-08-12
-$2.49M
derived: sum of 3 quarters · filed 2017-03-28
-$1.88M
derived: sum of 4 quarters · filed 2017-03-28
2016-03-31-$1.56M
derived: 10-K 12 month − 3 quarters · filed 2017-03-28
-$1.15M
derived: sum of 2 quarters · filed 2017-03-28
-$527.82K
derived: sum of 3 quarters · filed 2017-03-28
-$540.48K
derived: sum of 4 quarters · filed 2017-03-28
2015-12-31$408.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28
$1.03M
derived: sum of 2 quarters · filed 2017-03-28
$1.01M
derived: sum of 3 quarters · filed 2017-03-28
$3.30M
10-K · filed 2017-03-28
2015-09-30$618.28K
10-Q · filed 2016-11-10
$605.63K
derived: sum of 2 quarters · filed 2016-11-10
$2.89M
10-Q · filed 2016-11-10
2015-06-30-$12.66K
10-Q · filed 2016-08-12
$2.27M
10-Q · filed 2016-08-12
2014-12-31-$8.19M
10-K · filed 2015-03-19
2013-12-31-$3.86M
10-K · filed 2015-03-19